Show simple item record

dc.contributor.authorHuang, Zhengxiang
dc.contributor.authorWang, Weihao
dc.contributor.authorHuang, Lili
dc.contributor.authorGuo, Lixin
dc.contributor.authorChen, Chen
dc.date.accessioned2021-08-26T05:00:12Z
dc.date.available2021-08-26T05:00:12Z
dc.date.issued2020
dc.identifier.issn1930-7381
dc.identifier.doi10.1002/oby.22955
dc.identifier.urihttp://hdl.handle.net/10072/407322
dc.description.abstractObjective: This proof-of-concept study aimed to evaluate the efficacy and safety of suppression of insulin secretion in the treatment of obesity. Methods: A search of PubMed, Embase, and Cochrane databases was performed to identify randomized controlled trials (up to January 1, 2020) that used drugs that directly suppress insulin secretion (diazoxide or octreotide) in the treatment of obesity. The extracted data were analyzed using random-effects meta-analysis. Results: A total of seven randomized controlled trials were included, with four using diazoxide and three using octreotide to suppress insulin secretion. Suppression of insulin secretion significantly reduced fasting insulin level (mean difference: −3.94 mIU/L; 95% CI: −7.40 to −0.47) but slightly increased fasting blood glucose level (mean difference: 0.48 mmol/L; 95% CI: 0.24 to 0.72). Following the suppression of insulin secretion, significant reductions in body weight (mean difference: −3.19 kg; 95% CI: −5.71 to −0.66), BMI (mean difference: −1.65 kg/m2; 95% CI: −2.41 to −0.90), and fat mass (mean difference: −5.92 kg; 95% CI: −8.28 to −3.56) were observed compared with placebo in the pooled data. No significant difference in fat-free mass was observed (mean difference: 0.56 kg; 95% CI: −0.40 to 1.52). Conclusions: Results suggest that suppression of insulin secretion may lead to reduced body weight and fat mass with slightly increased blood glucose in individuals with obesity.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherWiley
dc.relation.ispartofpagefrom2098
dc.relation.ispartofpageto2106
dc.relation.ispartofissue11
dc.relation.ispartofjournalObesity
dc.relation.ispartofvolume28
dc.subject.fieldofresearchEndocrinology
dc.subject.fieldofresearchcode320208
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsNutrition & Dietetics
dc.subject.keywordsDIET-INDUCED OBESITY
dc.subject.keywordsMetabolism
dc.titleSuppression of Insulin Secretion in the Treatment of Obesity: A Systematic Review and Meta-Analysis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationHuang, Z; Wang, W; Huang, L; Guo, L; Chen, C, Suppression of Insulin Secretion in the Treatment of Obesity: A Systematic Review and Meta-Analysis, Obesity, 2020, 28 (11), pp. 2098-2106
dcterms.dateAccepted2020-06-23
dc.date.updated2021-08-24T23:28:42Z
gro.hasfulltextNo Full Text
gro.griffith.authorChen, Chen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record